Abata Therapeutics, Inc. — Form D/A
Abata Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2022-06-16. The offering totals $95.0M, of which $45.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-16
- Form: D/A
- Accession: 0001867989-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $95.0M
- Amount sold: $45.0M
- Remaining: $50.0M
- Investors: 7
- Date of first sale: 2021-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-403605
Issuer
- Name: Abata Therapeutics, Inc.
- CIK: 0001867989
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 100 FORGE ROAD, WATERTOWN, MA, 02472
- Phone: 857-230-0070
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Lorence Kim | Director | Lexington, MA |
| Shelley Chu | Director | Lexington, MA |
| David Kaufman | Director | Wilbraham, MA |
| SAMANTHA SINGER | Director | WATERTOWN, MA |
| SAMANTHA SINGER | Executive Officer | WATERTOWN, MA |
| LEONARD DRAGONE | Executive Officer | WATERTOWN, MA |
| VALERIE ODEGARD | Director | WATERTOWN, MA |
| STEPHEN SOFEN | Executive Officer | WATERTOWN, MA |
| SANDY LAZZARI | Executive Officer | WATERTOWN, MA |
| NAGESH MAHANTHAPPA | Director | WATERTOWN, MA |
| JOHN TRZUPEK | Executive Officer | WATERTOWN, MA |
| ABBIE CELNIKER | Director | Mt. Arlington, NJ |
| ABBIE CELNIKER | Executive Officer | Mt. Arlington, NJ |
| MITCH FINER | Director | WATERTOWN, MA |
| ELLEN CAHIR-MCFARLAND | Executive Officer | WATERTOWN, MA |
Other filings by this issuer (2)
More